Zamzam Drugs INC.
Zamzam Drugs INC. was paid $9K by Medicaid between Mar 2021 and Jul 2022, across 7 billing codes. Its largest line is U0002, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc — 32% of everything it billed.
BRONX, NY 10467
Next to other Community/Retail Pharmacy providers in New York
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 198 | $4K | |
| 2022 | 369 | $5K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 32% | 114 | 108 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 28% | 63 | 59 | $3K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 19% | 149 | 143 | $2K |
| 0013A | 9.4% | 23 | 23 | $871.77 | |
| 0012A | 6.3% | 40 | 40 | $587.16 | |
| 0011A | 5.1% | 35 | 35 | $471.33 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 143 | 136 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| E & R Home Health Care Provider LP | Sterling, VA | $18.04M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.